ArticleQuantitative imaging in medicine and surgery2025
Preoperative contrast-enhanced CT for predicting the macrotrabecular-massive subtype and its prognostic significance in hepatocellular carcinoma.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The macrotrabecular-massive subtype of hepatocellular carcinoma (MTM-HCC) is a special histological type of hepatocellular carcinoma (HCC), characterized by aggressive behavior and poor prognosis. Identification of MTM-HCC during pretreatment assessments may carry significant prognostic and therapeutic implications. This study aimed to develop a diagnostic prediction model for MTM-HCC using preoperative contrast-enhanced computed tomography (CECT) features and machine learning (ML) algorithms. Methods: Patients diagnosed with HCC who underwent liver resection surgery and preoperative CECT between October 2018 and December 2021 were retrospectively enrolled. These patients were subsequently categorized into MTM-HCC and non-MTM-HCC groups. Independent predictors of the MTM subtype were identified through multivariable logistic regression analyses. Clinical and CECT features were then selected to construct predictive models using ML algorithms. The performance of each model was evaluated using the area under the receiver operating characteristic (ROC) curve (AUC). Furthermore, Kaplan-Meier survival curves were employed to evaluate the association with early recurrence. Results: The final study cohort comprised 122 patients diagnosed with HCC (mean age: 53±10 years; 102 males), of which 46 tumors (37.7%) were classified as MTM-HCC. Multivariable analyses identified substantial necrosis as an independent predictor of MTM-HCC [odds ratio (OR) =2.23, 95% confidence interval (CI): 1.04-5.05; P=0.04]. The clinicoradiological histogram model, which integrated clinical imaging features and whole-tumor computed tomography (CT) histogram features, demonstrated AUC values of 0.917 (95% CI: 0.862-0.973) and 0.853 (95% CI: 0.728-0.977) in the training and test sets, respectively. Additionally, Kaplan-Meier survival curves indicated that substantial necrosis (P<0.01) was significantly associated with early recurrence. Conclusions: Substantial necrosis on CECT was an independent predictor of MTM-HCC and was associated with early recurrence of HCC. Meanwhile, the clinicoradiological histogram model based on preoperative CECT was shown to be useful in predicting MTM-HCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.